Cargando…
Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845888/ https://www.ncbi.nlm.nih.gov/pubmed/36660432 http://dx.doi.org/10.3389/fmolb.2022.1117323 |
| _version_ | 1784871019285053440 |
|---|---|
| author | Fusco, Nicola Malapelle, Umberto Criscitiello, Carmen |
| author_facet | Fusco, Nicola Malapelle, Umberto Criscitiello, Carmen |
| author_sort | Fusco, Nicola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9845888 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98458882023-01-18 Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers Fusco, Nicola Malapelle, Umberto Criscitiello, Carmen Front Mol Biosci Molecular Biosciences Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9845888/ /pubmed/36660432 http://dx.doi.org/10.3389/fmolb.2022.1117323 Text en Copyright © 2023 Fusco, Malapelle and Criscitiello. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Molecular Biosciences Fusco, Nicola Malapelle, Umberto Criscitiello, Carmen Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers |
| title | Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers |
| title_full | Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers |
| title_fullStr | Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers |
| title_full_unstemmed | Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers |
| title_short | Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers |
| title_sort | editorial: diagnosis and treatment of breast cancer in 2022: the rise of novel molecular biomarkers |
| topic | Molecular Biosciences |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845888/ https://www.ncbi.nlm.nih.gov/pubmed/36660432 http://dx.doi.org/10.3389/fmolb.2022.1117323 |
| work_keys_str_mv | AT fusconicola editorialdiagnosisandtreatmentofbreastcancerin2022theriseofnovelmolecularbiomarkers AT malapelleumberto editorialdiagnosisandtreatmentofbreastcancerin2022theriseofnovelmolecularbiomarkers AT criscitiellocarmen editorialdiagnosisandtreatmentofbreastcancerin2022theriseofnovelmolecularbiomarkers |